Sublingual sufentanil may be an option for outpatients who have had adverse reactions from or experienced lack of efficacy with IV fentanyl, a recent study has concluded.
The trial—one of the first of its kind to compare the two medications in the PACU following elective ambulatory surgery—concluded that sublingual sufentanil is a safe and effective alternative to IV fentanyl in this setting.
“The study was spearheaded by [co-investigator] Dr. Jacob Hutchins, whose literature